Bolt Biotherapeutics (BOLT) Stock: Buy, Sell, or Hold?
BOLT - Bolt Biotherapeutics, Inc. Common Stock
$3.45
-0.06 (-1.71%)
▼
5d:
-3.63%
30d:
-10.16%
90d:
-13.97%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 11, 2026
Get Alerted When BOLT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: BOLT shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: BOLT shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: BOLT is currently trading at $3.45, which is considered oversold relative to its 30-day fair value range of $3.55 to $3.94.
Technical Outlook: Technically, BOLT is in a strong downtrend. The price is currently testing key support at $3.38. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BOLT scores 62/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $29.00 (+740.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BOLT is in a strong downtrend. The price is currently testing key support at $3.38. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BOLT scores 62/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $29.00 (+740.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.55 -
$3.94
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (62/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 740.6% below Wall St target ($29.00)
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.55 -
$3.94
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.38
Resistance Level
$3.90
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.17
Wall Street Target
$29.00
(+740.6%)
Revenue Growth (YoY)
-99.7%
Share & Embed Analysis
Last updated: October 03, 2026 5:55 AM ET
Data refreshes hourly during market hours. Next update: 6:55 AM
Data refreshes hourly during market hours. Next update: 6:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BOLT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$92 | 46 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 65 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 76 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 42 HOLD |
